Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Capital expenditure | -463 | -601 | -511 | -519 | -497 |
| Investing cash flow | -238 | -629 | -383 | 1,065 | -433 |
| Financing cash flow | -2,104 | -400 | -1,794 | -2,579 | -30.3 |
| Dividends paid | -1,891 | -0.1 | -1,637 | -2,389 | -0.2 |
| Debt issued | 0.0 | 0.1 | 0.0 | 4.1 | 0.1 |
| Debt repaid | -0.1 | -4.0 | -2.6 | -0.5 | -0.7 |
| Effect of exchange rates | -245 | -240 | -139 | 19.5 | 16.3 |
| Net change in cash | 1,154 | 352 | 694 | 913 | 1,031 |
| Free cash flow | 3,033 | 780 | 2,361 | 1,908 | 997 |